SDGR Q2 2023 Earnings — Schrödinger, Inc. Revenue & Financial Results | Market Cap Arena

SDGRSchrödinger, Inc.

$935M

Q2 2023 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$35M-8.5% YoY

Gross Profit

$14M39.2% margin

Operating Income

-$61M-173.7% margin

Net Income

$4M12.2% margin

EPS (Diluted)

$0.06

QoQ Revenue Growth

-45.7%

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$21M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$842M

Total Liabilities

$230M

Stockholders' Equity

$611M

Cash & Equivalents

$286M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$35M	$38M	-8.5%
Gross Profit	$14M	$17M	-19.4%
Operating Income	-$61M	-$43M	-40.6%
Net Income	$4M	-$48M	+109.0%

Revenue Segments

Drug Discovery Contribution

$605,000100%

Geographic Segments

UNITED STATES

$24M68%

APAC

$6M18%

EMEA

$5M14%

Non-US

$156,0000%